Université Marie et Louis Pasteur at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Université Marie et Louis Pasteur brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on CAR therapies directed at CD123, from a bioreactor manufacturing pipeline for CAR NK cells to cord blood derived cells designed to avoid immune rejection. One strand tests anti-CD123 cells against the dendritic cells involved in psoriasis.

OrganizationESGCT 2026 Attendance
Poster
Wed Oct 28
1:30pm–3:30pm
NK CAR123-IL21: The Manufacturing pipeline using G-Rex bioreactors
Manufacturing
Poster
Thu Oct 29
2:00pm–4:00pm
Development of hypoimmunogenic CAR-T cell derived cord blood T cells
Immunotherapy and CAR T cells
Poster
Thu Oct 29
2:00pm–4:00pm
Functional evaluation of CAR-T anti-CD123 from immune-mediated inflammatory diseases patients for novel pDCs-targeted immunotherapy in psoriasis
Immunotherapy and CAR T cells

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Université Marie et Louis Pasteur

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction